IN THIS
ISSUE
INTERVIEW WITH
APTALIS PHARMACEUTICAL
TECHNOLOGIES’
PRESIDENT
JOHN FRAHER
Overcapacity
Strategies
Derek Hennecke
Defining the
Business
Josef Bossart, PhD
Diabetes
Management
Misty Hughes
Soft Tissue
Delivery
Jerry Gin, PhD
20
24
32
52
FEATURING
The science & business of drug development in specialty pharma, biotechnology, and drug delivery
William E.
Weiser, PhD
Outsourcing
Formulation
Development:
A Continuum on
the Road to Drug
Development
Lucie
Mondoulet,
PhD
Viaskin®:
Epicutaneous
Immunotherapy
for Treating Food
Allergies
Guy-Charles
Fanneau de la
Horie, MBA
Beyond
Monoclonals for
Severe
Autoimmune
Diseases
Transformational
Changes
73
Rosemarie Truman, PhD
HIV/AIDS
Vaccines
78
